Former FDA Director: U.S. Prevention and Control Not As Expected Outbreak May Re-emerge

Scott Gottlieb, the former head of the U.S. Food and Drug Administration, warned Sunday that the new U.S. coronasinn pneumonia outbreak could lead to a “new epidemic” or “large-scale outbreak” if states allow schools, businesses and other public places to let their guard down.

“It’s worrying that the outbreak is likely to continue to spread,” Gottlieb told CBS’ “Face the Nation, ” Gottlieb said Wednesday, according to The Nation, a US political news website. “

“While domestic control measures cannot be said to be a failure, I don’t think it has achieved the desired effect. Gottlieb admitted, “We had expected that by this time, the number of new confirmed cases and deaths across the country would have started to decline even more dramatically, and we are not seeing that now.” “

Former FDA Director: U.S. Prevention and Control Not As Expected Outbreak May Re-emerge

Gottlieb noted that the outbreak is still spreading in about 20 U.S. states. At the same time, different approaches are slowly reopening across the United States. “There are 230,000 new confirmed cases every day, and thousands of new deaths, and this should continue throughout the summer,” Gottlieb said. Gottlieb added that when people start to relax their guard and resume work, the “relatively mild” situation could turn into a new epidemic or large-scale outbreak at any time.

Looking ahead to the fall, Gottlieb agrees that the new drug, Redciewe, should be a way to control the rate of new coronary infections, while also relying on other antibody drugs and available vaccines. “The government accepts the fact that the epidemic continues to spread and is eager to open up the economy in this context, so it should redouble its investment in research and development and make sure that it does everything it can to get these things ready before the fall,” he stressed. “

Gottlieb, 47, is a Republican. During former President George W. Bush’s administration, he was deputy director of the Drug Administration. Trump nominated him in March 2017 to head the drug administration. Gottlieb’s “work performance” at the FDA has been “favorable” to many in Republicans and Democrats, citing his advocacy of curbing e-cigarette smoking among teenagers, accelerating the approval of generic drugs to lower drug prices, and encouraging competition to stimulate research and development of new drugs and technologies. In March last year, Gottlieb announced his departure and said he wanted more time with his family.